Cargando…

MYCL promotes the progression of triple-negative breast cancer by activating the JAK/STAT3 pathway

The present study aimed to investigate the underlying regulatory mechanism of MYCL proto-oncogene (MYCL) in triple-negative breast cancer (TNBC) progression. In vitro experiments were performed to confirm the functional roles of MYCL in TNBC, and its effects on the JAK/STAT3 pathway through flow cyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Hongnan, Li, Xiaojun, Wang, Wei, Hu, Yaofeng, Ren, Dongliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551653/ https://www.ncbi.nlm.nih.gov/pubmed/36177900 http://dx.doi.org/10.3892/or.2022.8418

Ejemplares similares

EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
por: Song, Xiang, et al.
Publicado: (2020)

C/EBPβ regulates the JAK/STAT signaling pathway in triple‐negative breast cancer
por: Wang, Shu, et al.
Publicado: (2021)

LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
por: Lv, Jianxin, et al.
Publicado: (2020)

Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis
por: Cheng, Jingwei, et al.
Publicado: (2017)

Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer
por: Chen, Di, et al.
Publicado: (2019)

Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
por: Mumin, Nuramalina H., et al.
Publicado: (2019)

Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis
por: Chang, Renxu, et al.
Publicado: (2018)

Down-Regulation of CXXC5 De-Represses MYCL1 to Promote Hepatic Stellate Cell Activation
por: Wu, Xiaoyan, et al.
Publicado: (2021)

Sanyin Formula Enhances the Therapeutic Efficacy of Paclitaxel in Triple-Negative Breast Cancer Metastases through the JAK/STAT3 Pathway in Mice
por: Wu, Chunyu, et al.
Publicado: (2022)

Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway
por: Qi, Yufeng, et al.
Publicado: (2023)

MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.
por: Fong, K. M., et al.
Publicado: (1996)

MYCL promotes iPSC-like colony formation via MYC Box 0 and 2 domains
por: Akifuji, Chiaki, et al.
Publicado: (2021)

TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway
por: Cao, Hongwen, et al.
Publicado: (2020)

The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells
por: Anderson, David A., et al.
Publicado: (2020)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway
por: Cui, Can, et al.
Publicado: (2019)

Domperidone Exerts Antitumor Activity in Triple-Negative Breast Cancer Cells by Modulating Reactive Oxygen Species and JAK/STAT3 Signaling
por: Shakya, Rajina, et al.
Publicado: (2023)

The potential roles of JAK/STAT signaling in the progression of osteoarthritis
por: Zhou, Qingluo, et al.
Publicado: (2022)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

JAK-STAT pathway and myogenic differentiation
por: Jang, You-Na, et al.
Publicado: (2013)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway
por: Liu, Xitao, et al.
Publicado: (2021)

HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway
por: Liu, Yi, et al.
Publicado: (2017)

Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway
por: Liu, Tianyi, et al.
Publicado: (2021)

Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL
por: Suzuki, Kazuhito, et al.
Publicado: (2016)

Hydroxyzine Induces Cell Death in Triple-Negative Breast Cancer Cells via Mitochondrial Superoxide and Modulation of Jak2/STAT3 Signaling
por: Shakya, Rajina, et al.
Publicado: (2022)

SEPTIN3 Promotes Progression of Triple-Negative Breast Cancer via Activating Wnt Pathway
por: Wang, Guo-Zhou, et al.
Publicado: (2023)

Knockdown of NCAPG promotes the apoptosis and inhibits the invasion and migration of triple‑negative breast cancer MDA‑MB‑231 cells via regulation of EGFR/JAK/STAT3 signaling
por: Li, Juanyun, et al.
Publicado: (2023)

The JAK/STAT signaling pathway: from bench to clinic
por: Hu, Xiaoyi, et al.
Publicado: (2021)

Association analyses of the JAK/STAT signaling pathway with the progression and prognosis of colon cancer
por: Tang, Shengbo, et al.
Publicado: (2019)

Mechanisms of JAK/STAT pathway negative regulation by the short coreceptor Eye Transformer/Latran
por: Fisher, Katherine H., et al.
Publicado: (2016)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway
por: Sun, Yuechao, et al.
Publicado: (2023)

Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets JAK2/STAT3 Signaling, Migration and Invasion of Triple-Negative Breast Cancer Cells
por: Bouaouiche, Sarra, et al.
Publicado: (2021)

The JAK/STAT Pathway Is Involved in Synaptic Plasticity
por: Nicolas, Céline S., et al.
Publicado: (2012)

Methotrexate Is a JAK/STAT Pathway Inhibitor
por: Thomas, Sally, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ik1jlu5peoovhajvijqrlsdtjd